LeonaBio (LONA) Net Cash Flow (2019 - 2026)

LeonaBio (LONA) has 8 years of Net Cash Flow data on file, last reported at -$36.4 million in Q1 2026.

• On a quarterly basis, Net Cash Flow fell 65.53% year-over-year to -$36.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 112.39% increase from a year earlier, with the FY2025 full-year figure at $20.8 million, up 149.44% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$36.4 million, down from $48.4 million in the prior quarter.
• Over the last five years, Net Cash Flow for LONA reached as high as $48.4 million in Q4 2025 and fell as low as -$36.4 million in Q1 2026.
• Historically, Net Cash Flow has averaged -$4.5 million across 5 years, with a median of -$5.0 million in 2024.
• Across the five-year window, Net Cash Flow sank 686.75% in 2022 and surged 268.12% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $9.1 million in 2022, then tumbled by 316.39% to -$19.8 million in 2023, then slumped by 45.78% to -$28.8 million in 2024, then jumped by 268.12% to $48.4 million in 2025, then plunged by 175.29% to -$36.4 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$36.4 million in Q1 2026, $48.4 million in Q4 2025, and $986000.0 in Q3 2025.